WORKATO
10.11.2021 15:03:10 CET | Business Wire | Press release
Workato, the leader in enterprise automation, today announced $200 million in Series E funding led by Battery Ventures, with equal participation from Insight Partners, Altimeter Capital and Tiger Global. Geodesic Capital and Redpoint Ventures also participated in this round of financing. The new funding values Workato at $5.7 billion and comes just nine months after its $110 million Series D. Workato has raised over $420 million in total funding to date.
The investment comes at a time of rapid growth for Workato and the automation market as a whole, as enterprises recognise the urgent need to increase their agility, innovation and efficiency against a backdrop of transformation and change. The pandemic has driven an even greater need for business excellence, and companies have responded by automating core workflows; seeking out low-code tools that empower employees to work quickly and autonomously.
Following the launch of its EMEA data centre in Frankfurt earlier this year, Workato plans to use the funds to further capitalise on the market opportunity in the region. The company has grown by 243% in Europe alone over the last 12 months as enterprises, in the wake of the pandemic have turned to workflow automation to boost business efficiencies; seeking out low-code tools that empower employees to work quickly and autonomously. Workato has increased headcount in the region by 273% and its customer base in EMEA has seen 2.14x growth this year and now includes enterprises such as Freenow and Adevinta.
The funds raised will go towards expanding its EMEA customer success team and senior leadership, holding the first user conference in Europe, setting up a customer advisory board in Europe and expanding its ecosystem of partners. The investment will also go towards boosting its European presence. The company currently has operations in Ireland, Spain, France, Germany, UK and Israel and is now looking to open additional offices in regions including Benelux and the Nordics to serve customers there.
A key hire made in response to Workato’s strong growth and expansion plans in Europe is that of Robert Ekstrom, who joins Workato as VP & GM EMEA, based in Munich. Robert brings over twenty years’ management experience within the enterprise software market, having held management roles at leading multinationals including Dell, EMC and Xerox. Prior to joining Workato, he was VP & GM at Blue Prism, an enterprise intelligent automation vendor.
The latest funding will also be used globally to further accelerate the company’s product roadmap and leadership in enterprise automation, in addition to continuing to drive the integration-led automation movement. Workato, already a leader in connecting and integrating applications, is launching the “10,000 Connector Initiative” with the acquisition of RailsData, which specialises in the connectivity of applications, databases, and devices using APIs. With thousands of applications used by an enterprise, connectivity is critical to achieving automation at scale.
Historically, companies have been forced to deploy a variety of integration and automation tools to optimise their processes at the data, process, API and UX levels. This model is highly inefficient, and companies have flocked to Workato because it provides all of these capabilities in a single, low-code platform that allows business users and IT departments to collaborate on process automation.
"Businesses are still struggling to achieve true transformation because RPA and integration tools cannot scale to address the needs of enterprises today," said Vijay Tella, Workato CEO and Co-founder. "Workato’s enterprise automation platform, a single platform for automation and integration that can be used by both Business and IT, addresses the challenges companies face when trying to automate at scale, enabling enterprises to achieve the speed and agility necessary for organisational transformation. We’re excited to put this new round of funding to work for our customers as they continue to push the boundaries of innovation .”
He added: “The European market is beginning to catch up in terms of adoption of Enterprise Automation as enterprises seek a means of driving business outcomes at scale as they recover from setbacks caused by the pandemic. We are pleased to be able to boost our operations in the region through this investment and enhance services for our European customers.”
“Since leading Workato’s Series B in 2018, we’ve been excited to see the steady growth of usage among Workato’s customers—many of them leaders in their respective industries—and Workato’s solidifying position as a leader in the automation market, one of the fastest-growing sectors in technology,” said Neeraj Agrawal, a general partner at Battery Ventures. “We’ve had a front-row seat to watch Workato truly transform many of its customers’ businesses, which is one reason why we and other existing investors in the company are excited to lead this new funding round.”
“The events of the past 10 months have made operational excellence more critical than ever, and businesses understand that enterprise automation is a cornerstone to achieving the heightened agility, innovation and performance they need to succeed in any environment,” said Pauline Yang, partner, Altimeter Capital. “The market for automation products will only continue to expand, and we believe that Workato has the best technology, partnerships and leadership team in place to capitalise on this exciting opportunity.”
Customers trust Workato as their automation platform of choice and three out four customers automate business processes across three or more business functions.
-ends-
Notes to editors:
More than 11,000 customers now use Workato’s enterprise automation platform to automate their critical business processes. In the past 12 months, Workato has:
● More than doubled new ARR, with growth accelerating every quarter
● Nearly doubled the customer base with additions like Freenow, Adevinta, Nokia, Stitch Fix, Gitlab, NYU and many others
● More than tripled the growth in business processes automated by customers and quadrupled the workload per customer
● Expanded in EMEA with a new GDPR-compliant data centre in Frankfurt
● Acquired RailsData to create an application connector factory; increasing the number of application connectors by over 10x in the next few years
● More than doubled employee headcount
● Been recognised as a leader in Gartner’s Enterprise iPaaS Magic Quadrant for the fourth year in a row - with the largest positive movement of any leader this year
● Hosted its first user conference, Workato Automate, which attracted more than 12,000 participants
● Been named to the Forbes Cloud 100, the definitive ranking of the top 100 private cloud companies in the world
● Been recognised in the Deloitte Fast 500 as one of the top 100 fastest growing companies globally
About Workato
The leader in enterprise automation, Workato helps organisations work faster and smarter without compromising security and governance. Built for Business and IT users, Workato is trusted by over 7,000 of the world's top brands like Broadcom, Intuit, Box, Autodesk, and HubSpot. Headquartered in Mountain View, Calif., Workato is backed by Altimeter Capital, Battery Ventures, Insight Venture Partners, Tiger Global, and Redpoint Ventures. For more information, visit www.workato.com or connect with us on social media:
● Blog: https://www.workato.com/the-connector/
● Business Systems Community: https://systematic.workato.com/
● Twitter: http://www.twitter.com/workato
● LinkedIn: https://www.linkedin.com/company/workato
View source version on businesswire.com: https://www.businesswire.com/news/home/20211110005682/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release
Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release
About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release
Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break
Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti
Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release
Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom